Sharing of cutting-edge applications of PLGF | PLGF and gestational diabetes
Gestational diabetes mellitus (GDM) is one of the most common pregnancy complications. Most of the glucose metabolism of GDM patients can return to normal after delivery, but the probability of developing type II diabetes will increase in the future. The clinical manifestations of pregnant women with gestational diabetes are complicated, and both the mother and the fetus are at risk, and clinical attention should be paid to it. At present, in order to diagnose gestational diabetes, pregnant women between 24-28 weeks of gestation generally should undergo a sugar screening test. However, with the progress of research, it is found that placental growth factor (PLGF) may be able to indicate the occurrence of gestational diabetes.
Academic Sharing | The impact of fetal growth restriction on long-term diseases of the mother and offspring
Fetal growth restriction (FGR), also known as intrauterine growth restriction (IUGR), is a common pregnancy complication associated with a variety of adverse perinatal outcomes. Globally, FGR affects nearly 10% of pregnancies. The incidence rate in my country is 6.39%, which is the second leading cause of perinatal death. In this issue, let's talk about the impact of fetal growth restriction on the long-term disease of the mother and offspring.
Academic Sharing | Uterine Arterial Doppler Ultrasound in the Second Trimester and Adverse Pregnancy Outcomes Original Orient Biomedicine Department Orden Medical July 23
The second trimester generally refers to the period from 14 weeks to 27 weekends of pregnancy. In the second trimester, because the placenta has formed, the fetus has entered a relatively safe stage. However, the abnormality of some test indicators in the second trimester is often a predictor of adverse pregnancy outcomes. In this issue, let’s talk about the relationship between uterine artery Doppler ultrasound in the second trimester (including uterine artery resistance index RI, uterine artery pulsatility index PI, uterine artery early diastolic notch) and adverse pregnancy outcomes.
Literature Interpretation | How to effectively screen for PE and FGR in the first trimester
Preeclampsia (PE) is not only one of the main causes of maternal and fetal death, but also other adverse pregnancy outcomes, such as fetal growth restriction (FGR). At present, PE and FGR are still clinical problems that plague obstetrics. "Comparison of preeclampsia and fetal growth restriction screenings at first trimester in a high-risk population" compares combined maternal risk factors, mean arterial pressure (MAP), uterine artery pulsatility index (UTPI), placental growth factor (PLGF), pregnancy-related The sensitivity and specificity of plasma protein (PAPP-A) to PE and FGR screening, and it was found that combining these indicators can better identify pregnant women at high risk of PE and FGR in high-risk populations. This article is a specific interpretation of this document